Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Vaccine

Breakthrough vaccine could help cure pancreatic cancer

Early trial results suggest personalised vaccines could stop deadly disease returning

The Independent UK

COVID vaccine rights waiver within reach, WTO chief says ahead of meeting

An international agreement on waiving intellectual property rights for COVID-19 vaccines is within reach ahead of a global trade meeting next week, the head of the World Trade Organization said on Wednesday.

Reuters

Covid vaccine technology 'could hold the key to pancreatic cancer cure'

Pancreatic cancer claims 10,000 lives in the UK each year and is the most deadly form of common cancer, with nine out of 10 patients dying within two years of diagnosis

Daily Mirror

From analysis to the latest developments in health,
read the most diverse news in one place.

Novavax COVID-19 shot gets backing from FDA advisory panel

WASHINGTON — Novavax Inc.’s coronavirus vaccine won the support of a panel of U.S. government advisers, paving the way for authorization of another tool to fight the coronavirus.

Tribune News Service

Can new COVID-19 vaccine win over the anti-vaxxers?

With three COVID-19 vaccines already authorized by the U.S. Food and Drug Administration, Americans have easy access to plenty of shots.

Tribune News Service

Novavax's COVID-19 Vaccine For Adults Over 18 Backed By FDA Advisors: What's Next?

Novavax, Inc. (NASDAQ: NVAX) announced the U.S.

Benzinga

Novavax Shares Gain Following FDA Advisory Committee's Positive Vote On Emergency Use Authorization (EUA) For COVID-19 Vaccine

Novavax’s (NASDAQ: NVAX) COVID-19 vaccine (NVX-CoV2373) receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee (VRBPAC), recommending FDA to grant Emergency Use Authorization (EUA) for individuals aged 18 years and over.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Advisers to the FDA back Novavax COVID vaccine

Advisers to the Food and Drug Administration overwhelmingly voted to recommend that it authorize Novavax's two-dose vaccine against COVID-19.

WEKU

FDA advisers recommend Novavax COVID shot in adults

Officials said Novavax could fill an unmet need because there aren't non-mRNA COVID vaccines that can serve as first line defenses.

Axios

FDA advisers back Novavax COVID-19 shots as new US option

A more traditional kind of COVID-19 vaccine has moved a step closer to the U.S. market

The Independent UK

MTG falls for fake Twitter account

The fake account misleadingly tweeted that Pfizer's vaccine has caused widespread miscarriages

Salon

What's Going On With Novavax Stock Today?

Novavax Inc (NASDAQ: NVAX) shares have been halted since the pre-market session as the U.S. Food and Drug Administration holds a meeting to determine the fate of the company's COVID-19 vaccine.

Benzinga

Bavarian Nordic eyes more monkeypox vaccine orders amid global "wake-up call"

Biotechnology company Bavarian Nordic expects to sign more contracts for its vaccine against monkeypox after "overwhelming" interest from governments around the world, its management told investors on Tuesday.

Reuters

Vallance recalls ‘darkest days’ and vaccine that ‘changed course of pandemic’

Sir Patrick Vallance collected an honour from the Duke of Cambridge at Buckingham Palace for helping to lead the UK’s battle against coronavirus.

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Moderna Commences Late-stage Study of Flu Vaccine Candidate

Moderna, Inc. (NASDAQ: MRNA) today announced Initiation of Patient dosing in the phase 3 clinical study of its seasonal influenza vaccine candidate mRNA-1010 for patients with influenza.

Benzinga

J&J Serves Notice To Emergent For Terminating COVID-19 Shot Contract As Two Accuse Each Other Of Breach Of Agreement

Johnson & Johnson (NYSE: JNJ) has made another move towards severing its Covid-19 vaccine manufacturing ties with contract manufacturer Emergent Biosolutions, Inc. (NYSE: EBS).

Chicago Tribune

The current state of COVID-19 should invite hope — not complacency

The famous Robert Frost poem “The Road Not Taken” begins: “Two roads diverged in a yellow wood, / And sorry I could not travel both.” The United States and the rest of the world faced a fork in the road with two possible options at the outset of the COVID-19…

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Polio outbreak in Pakistan worsens as eighth child reported paralysed

Investigation launched as first cases in a year blamed on vaccine refusal fuelled by clerics and falsification of records by parents

Wales Online

AstraZeneca boss 'wouldn't change a thing' despite Covid vaccine 'setbacks'

Jab saved one million lives, says Sir Pascal Soriot

The Canberra Times

ACT parliament passes new COVID-19 powers

It would give government ministers the power to make decisions around certain public directions.

Dynamite News

Technology: Google's new update for Pixel phones adds useful information to lock screen

American tech giant Google's new update for Pixel phones has added yet more features to At a Glance, which is a widget designed to surface important information on home and lock screens. Read more on Dynamite News:

ABC News

Free flu vaccine program could suffer from limited supply, pharmacist says

A pharmacist warns some Victorians are at risk of missing out on flu shots as demand for vaccines soars across the nation, and the state opposition blames the Andrews government for the "chaos".

Salon

Novavax's new shot may sway anti-vaxxers

Experts hope the new COVID vaccine, which uses older biotechnology, could help the unvaccinated come around

Salon

Why the malaria vaccine took 35 years

Malaria's complex biology played a role in the delay, but experts say there was also a lack of urgency and funding

1 … 239 240 241 242

People

Marjorie Taylor Greene

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.